Catalano, Maria G <br/><br/>
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.  [electronic resource] 

 -  The Journal of endocrinology  Nov 2006 
 - 465-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-0795 
<br/><br/><label>Standard No.: </label>10.1677/joe.1.06970  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Antigens, Neoplasm--analysis<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis<br/>Carcinoma--drug therapy<br/>Caspase 3--metabolism<br/>Cell Cycle--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>DNA Fragmentation<br/>DNA Topoisomerases, Type II--analysis<br/>DNA-Binding Proteins--analysis<br/>Doxorubicin--therapeutic use<br/>Histone Deacetylase Inhibitors<br/>Histones--metabolism<br/>Humans<br/>RNA, Messenger--analysis<br/>Thyroid Neoplasms--drug therapy<br/>Valproic Acid--therapeutic use